| JYHB2001321 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2020-12-30 | view |
| JYHB2001320 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-10 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2020-12-30 | view |
| JYHB2001373 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 辉瑞制药有限公司 | Viatris Pharmaceuticals (Dalian) Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Filed | 2020-09-02 | view |
| JYHB2001374 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2020-08-21 | 辉瑞制药有限公司 | Viatris Pharmaceuticals (Dalian) Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Filed | 2020-09-02 | view |
| JYHB1801285 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2018-11-12 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2018-12-05 | view |
| JYHB1801286 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2018-11-12 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2018-12-05 | view |
| JYHZ1700230 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | License Renew | 2018-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2018-03-28 | view |
| JYHZ1700231 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | License Renew | 2018-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2018-03-28 | view |
| JYHB1700682 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2017-05-13 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2017-07-18 | view |
| JYHB1700683 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2017-05-13 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions LLC;Pfizer Italia SRL | Certificate Issued | 2017-07-18 | view |
| JXHL1300126 | 酒石酸托特罗定缓释硬胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Import Drug Application | 2013-04-12 | 法默森公司 | Famosen Co Ltd;Pharmathen SA | Certificate Issued | 2015-11-27 | view |
| JXHL1300127 | 酒石酸托特罗定缓释硬胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Import Drug Application | 2013-04-10 | 法默森公司 | Famosen Co Ltd;Pharmathen SA | Certificate Issued | 2015-11-27 | view |
| JYHB1400901 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2014-07-04 | Pfizer Italia s.r.l | Pfizer Italia SRL;Catalent Pharma Solutions LLC | Certificate Issued | 2015-03-03 | view |
| JYHB1400900 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2014-07-04 | Pfizer Italia s.r.l | Pfizer Italia SRL;Catalent Pharma Solutions LLC | Certificate Issued | 2015-03-03 | view |
| JYHB1201252 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2012-11-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions Inc;Pfizer Italia SRL | Certificate Issued | 2013-06-13 | view |
| JYHB1201250 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | Supplementary Application | 2012-11-09 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Catalent Pharma Solutions Inc;Pfizer Italia SRL | Certificate Issued | 2013-06-13 | view |
| CXHR0900226 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs | State Standards | 2009-10-13 | 广东中大南海海洋生物技术工程中心有限公司 | Guangdong Zhongda Nanhai Ocean Biological Technology Engineering Centre Co Ltd | Certificate Issued | 2010-08-27 | view |
| CXHL0601048 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(5) | New Drug Application | 2007-01-10 | 广东中大南海海洋生物技术工程中心有限公司 | Guangdong Zhongda Nanhai Ocean Biological Technology Engineering Centre Co Ltd | Certificate Issued | 2009-07-21 | view |
| JXHS0700026 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(3.1) | Import Drug Application | 2007-05-31 | Pfizer Italia s.r.l. | Pfizer Italia SRL;Cardinal Health Inc | Certificate Issued | 2008-06-26 | view |
| JXHS0700025 | 酒石酸托特罗定缓释胶囊 | tolterodine tartrate | Capsules, extended release | Chemical Drugs(3.1) | Import Drug Application | 2007-05-31 | Pfizer Italia s.r.l. | Pfizer Italia SRL;Cardinal Health Inc | Certificate Issued | 2008-06-26 | view |
